Transforming Cancer Treatment: The Rise of CAR T-Cell Therapy
In recent years, Chimeric Antigen Receptor (CAR) T-cell therapy has emerged as a revolutionary approach in the treatment of certain types of cancer. This innovative therapy involves reprogramming a patient's own immune cells to recognize and attack cancer cells, offering new hope where conventional treatments have fallen short.
Understanding CAR T-Cell Therapy
CAR T-cell therapy harnesses the power of the immune system, particularly T cells, to combat cancer effectively. The process begins by extracting a patient's T cells from their blood. These cells are then genetically engineered in a laboratory to express CARs on their surface. CARs are synthetic receptors that enable T cells to recognize specific antigens present on cancer cells.
Mechanism of Action
Download latest CAR-T Market Report @ https://www.delveinsight.com/s....ample-request/chimer
